dupilumab

Ligand id: 7574

Name: dupilumab

Immunopharmacology Disease
Disease X-Refs Comment References
Atopic dermatitis Disease Ontology: DOID:3310
OMIM: 603165
Dupilumab is approved to treat atopic dermatitis (eczema).
Asthma Disease Ontology: DOID:2841
OMIM: 600807
Clinical candidate for asthma (see NCT02134028, Phase 3).